Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | RAB9A | P51151 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | RORC | P51449 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL930295 | 1.00 | MAPT (0.46) | MAPTPOLBGAAHPGDALDH1A1 | |
| SCHEMBL7122480 | 0.98 | MAPT (0.44) | MAPTPOLBGAAHPGDALDH1A1 | |
| SCHEMBL498606 | 0.98 | MAPT (0.47) | MAPTPOLBGAAHPGDALDH1A1 | |
| SCHEMBL8133890 | 0.93 | — | — | |
| SCHEMBL28794480 | 0.89 | MAPT (0.42) | MAPTPOLBGAAHPGDALDH1A1 | |
| SCHEMBL497608 | 0.87 | — | — | |
| Acetic Acid SCHEMBL11173187 | 0.87 | BRD4 (0.47) | MAPTPOLBGAAHPGDALDH1A1 | |
| SCHEMBL28657261 | 0.86 | MAPT (0.40) | MAPTPOLBGAAHPGDALDH1A1 | |
| Hydrochloric Acid SCHEMBL11286601 | 0.85 | — | — | |
| Methylamine SCHEMBL28610020 | 0.81 | MAPT (0.46) | MAPTPOLBGAAHPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 617 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4590782-A1 | GAS-PHASE COMPOSITION FOR INHIBITING CORROSION EXPOSED TO CONDENSED WATER | Arkema France (FR) | 2025-07-30 | — | — | EP | claimed |
| CN-119861532-A | Gold nanocluster photoresist added with coinitiators and method | 浙江大学 | 2025-04-22 | — | — | CN | claimed |
| CN-119465190-A | Selective cleavage method of small molecule mercaptan-mediated lignin beta-O-4 connection | 烟台先进材料与绿色制造山东省实验室 | 2025-02-18 | — | — | CN | claimed |
| CN-119039193-A | Method for synthesizing (cyclohexylthio) benzene compound | 常州大学 | 2024-11-29 | — | — | CN | claimed |
| EP-4441164-A1 | FOAMING COMPOSITION COMPATIBLE WITH STEEL FOR THE ASSISTED RECOVERY OF HYDROCARBONS | ARKEMA FRANCE (FR) | 2024-10-09 | — | — | EP | claimed |
| CN-118335382-A | Conductive paste based on modified nano powder and preparation method thereof | 长沙连古科技有限公司 | 2024-07-12 | — | — | CN | claimed |
| WO-2024062191-A1 | GAS-PHASE COMPOSITION FOR INHIBITING CORROSION EXPOSED TO CONDENSED WATER | ARKEMA FRANCE (FR) | 2024-03-28 | — | — | WO | claimed |
| CN-116261378-A | Polythiophene derivative film, and preparation method and application thereof | 深圳职业技术学院 | 2023-06-13 | — | — | CN | claimed |
| WO-2023099848-A1 | FOAMING COMPOSITION COMPATIBLE WITH STEEL FOR THE ASSISTED RECOVERY OF HYDROCARBONS | ARKEMA FRANCE (FR) | 2023-06-08 | — | — | WO | claimed |
| US-11548906-B2 | Processes for the preparation of SGLT-2 inhibitors, intermediates thereof | EMMENNAR PHARMA PRIVATE LIMITED (IN) | 2023-01-10 | — | — | US | claimed |
| US-20020058788-A1 | Facile deprotection of Fmoc protected amino groups | DISCOVERY PARTNERS INTERNATIONAL, INC. | 2002-05-16 | — | — | US | claimed |
| US-6110529-A | USING A METALORGANIC REAGENT SOLUTION CONSISTING A METALORGANIC COMPLEX DISSOLVED IN A SOLVENT OR SUSPENDING AGENT TO DEPOSIT A METAL, A METAL OXIDE OR A METAL SULFIDE | ATMI, INC. | 2000-08-29 | — | — | US | claimed |
| US-6107495-A | REACTING SPECIFIED 1-(2- OR 3-THIENYL) CYCLOHEXANES WITH A 1,5-DIHALOPENTANE TO FORM CYCLIC (THIENYLCYCLOHEXYL)AMINES SUCH AS 2-ALKYL-(3-THIENYL)CYCLOHEXYL PIPERIDINE; USE AS INTERMEDIATES TO RADIOACTIVE LABELLED MOLECULES | SOCIETE D'EXPANSION SCIENTIFIQUE EXPANSIA (FR) | 2000-08-22 | — | — | US | claimed |
| EP-0873343-A4 | METAL COMPLEX SOURCE REAGENTS FOR CHEMICAL VAPOR DEPOSITION | ADVANCED TECH MATERIALS (US) | 1999-12-15 | — | — | EP | claimed |
| EP-0873343-A1 | METAL COMPLEX SOURCE REAGENTS FOR CHEMICAL VAPOR DEPOSITION | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 1998-10-28 | — | — | EP | claimed |
| WO-1996040690-A1 | METAL COMPLEX SOURCE REAGENTS FOR CHEMICAL VAPOR DEPOSITION | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 1996-12-19 | — | — | WO | claimed |
| US-5147841-A | Method for the preparation of metal colloids in inverse micelles and product preferred by the method | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1992-09-15 | — | — | US | claimed |
| EP-0276700-A1 | 8-Cyano-1-cyclopropyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids, process for their preparation, and antibacterial agents containing them | BAYER AG (DE) | 1988-08-03 | — | — | EP | claimed |
| EP-0007070-B1 | 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS HAVING DOPAMINE RECEPTOR BLOCKING ACTIVITY | SMITHKLINE BECKMAN CORPORATION (US) | 1983-01-19 | — | — | EP | claimed |
| US-4005138-A | REACTION OF DISULFIDES OR MERCAPTANS WITH NITROGEN OXIDES AND HYDROGEN FLUORIDE | CIBA-GEIGY CORPORATION (US) | 1977-01-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020058788-A1 | Facile deprotection of Fmoc protected amino groups | DNPEP, LNPEP, NPEPPS | MAPT 1188/4885POLB 4116/4885GAA 3875/4885 |
| US-11548906-B2 | Processes for the preparation of SGLT-2 inhibitors, intermediates thereof | SLC5A2, SLC5A1, SLC2A4 | MAPT 340/4885POLB 4657/4885GAA 147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.